Hearing Aids Presented as Neuroprotective Tools to Combat Cognitive Decline

Untreated hearing loss is identified as the leading modifiable risk factor for cognitive decline and dementia. When the brain no longer receives clear auditory input, it undergoes maladaptive plasticity, reallocating auditory regions to other senses and overloading executive functions and long‑term memory.

Modern hearing aids, equipped with artificial‑intelligence algorithms, are portrayed as “technological drugs” that preserve gray‑matter volume and keep temporal‑lobe synaptic connections active. Experts argue that early adoption of precision hearing aids should be treated as a routine preventive measure, comparable to blood‑pressure monitoring, to maintain cognitive vitality and reduce social isolation that accelerates senile decline.